Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Fischman

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Vascular and Interventional Radiology : JVIR|February 11, 2024
Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular CarcinomaKirema Garcia-Reyes, Ricki A Gottlieb, Kartikeya M Menon, et al.
Radiology|March 5, 2024
Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 PatientsRaj Ayyagari, Saumik Z Rahman, Kevin Grizzard, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched studyBrett Marinelli, Edward Kim, Antonio D'Alessio, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Vascular and Interventional Radiology : JVIR|February 11, 2024
Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular CarcinomaKirema Garcia-Reyes, Ricki A Gottlieb, Kartikeya M Menon, et al.
Radiology|March 5, 2024
Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 PatientsRaj Ayyagari, Saumik Z Rahman, Kevin Grizzard, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched studyBrett Marinelli, Edward Kim, Antonio D'Alessio, et al.
Pageof 5